Jincheon, South Korea

Hui Kwon Kim

This inventor holds 2 USPTO granted patents and 3 published patent applications and 1 EPO patent. Top assignee: Yonsei University. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hui Kwon Kim. Retrieved from https://idiyas.com/inventor/hui-kwon-kim

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

 

Average Co-Inventor Count = 2.4

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations in Genome Editing by Hui Kwon Kim

Introduction

Hui Kwon Kim is a notable inventor based in Jincheon-gun, South Korea. He has made significant contributions to the field of genome editing, particularly through his innovative methods for modifying target nucleic acids within cellular genomes. His work has the potential to expand the applications of genome editing, making it a vital area of research.

Latest Patents

Hui Kwon Kim holds a patent for a "Method for modifying target nucleic acid in genome of cell." This patent describes a novel approach that utilizes a unique PAM sequence to modify target nucleic acids in the genome of a cell. The method allows for genome editing at previously untargetable positions, thereby broadening the scope of genome editing applications. He has 1 patent to his name.

Career Highlights

Hui Kwon Kim is affiliated with Yonsei University, where he conducts his research and development in the field of genome editing. His academic background and ongoing research contribute to advancements in genetic engineering and biotechnology.

Collaborations

Hui Kwon Kim collaborates with esteemed colleagues, including Hyong Bum Kim and Myung Jae Song. Their combined expertise enhances the research output and innovation in their respective fields.

Conclusion

Hui Kwon Kim's contributions to genome editing represent a significant advancement in biotechnology. His innovative methods and collaborative efforts continue to push the boundaries of what is possible in genetic research.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…